Pub. Date : 1993 May-Jun
PMID : 8321736
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | STUDY OBJECTIVE: To compare the clinical safety and efficacy of ramipril, a new long-acting nonsulfhydryl inhibitor of angiotensin-converting enzyme (ACE), with enalapril. | Ramipril | angiotensin I converting enzyme | Homo sapiens |
| 2 | STUDY OBJECTIVE: To compare the clinical safety and efficacy of ramipril, a new long-acting nonsulfhydryl inhibitor of angiotensin-converting enzyme (ACE), with enalapril. | Ramipril | angiotensin I converting enzyme | Homo sapiens |
| 3 | A larger average decrease in plasma ACE activity was achieved with ramipril over all dosages (71%) compared with that for enalapril (48%), suggesting that ramipril has greater ACE inhibition in the circulation. | Ramipril | angiotensin I converting enzyme | Homo sapiens |
| 4 | A larger average decrease in plasma ACE activity was achieved with ramipril over all dosages (71%) compared with that for enalapril (48%), suggesting that ramipril has greater ACE inhibition in the circulation. | Ramipril | angiotensin I converting enzyme | Homo sapiens |
| 5 | A larger average decrease in plasma ACE activity was achieved with ramipril over all dosages (71%) compared with that for enalapril (48%), suggesting that ramipril has greater ACE inhibition in the circulation. | Ramipril | angiotensin I converting enzyme | Homo sapiens |